Insulet | PODD - 税前利润



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.74B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.69M 193K 2026-06
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Boston Scientific USD 1.42B 261M 2026-06
Cardinal Health USD 630M 32M 2025-12
Cooper Companies USD 192.2M 75.4M 2025-12
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Globus Medical USD 157.07M 12.16M 2026-03
ICU Medical USD -3.97M 11.93M 2026-03
Inogen USD -6.06M 467K 2024-09
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
J&J USD 8.66B 839M 2026-06
Medtronic USD 2.45B 1.04B 2026-03
Merit Medical Systems USD 53.55M 2.49M 2026-03
Roche Holding CHF 11.17B 6.38B 2026-06
Solventum Corp USD 332M 179M 2025-12
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD -19.88M 24.56M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
West Pharmaceutical Services USD 180.1M 18.6M 2026-03
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06